Notre Dame Advanced Diagnostics and Therapeutics | Mar. 11, 2013

A potential landmark paper by Notre Dame researchers could help identify and adjust important parameters for designing targeted nanoparticle-based cancer treatments for years to come.

The results of the study shed light on a decades-long debate among cancer researchers.

The paper is authored by Jared Stefanick, Jonathan Ashley, Tanyel Kiziltepe, and Basar Bilgicer.

Read more at Notre Dame Advanced Diagnostics and Therapeutics